Home » Alexion Buys Patents From German Biotech for Infant Disorder
Alexion Buys Patents From German Biotech for Infant Disorder
Pharmaceuticals Inc. acquired patents and assets for a possible therapy for a ultra-rare genetic disorder for $3 million in cash from Germany-based Orphatec Pharmaceuticals GmbH.
Mass High Tech
Mass High Tech
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May